Intradermal injection of IL-23 results in skin inflammation in mice [30] and delivery of exogenous IL-23 in IL-23p19 KO mice restores susceptibility to autoimmune diseases [8], [28]. This evidence concerns the gene IL23A and autoimmune disease.